ReviewTherapeutics and clinical risk management2017

Efficacy and safety outcomes of sofosbuvir-based treatment regimens for hepatitis C virus-infected patients with or without cirrhosis from phase III clinical trials.

Young-Mo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.